English  |  正體中文  |  简体中文  |  Total items :2828323  
Visitors :  32238670    Online Users :  1020
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsieh rk"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-25 of 33  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2023-04-11 Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group,
國家衛生研究院 2021-05 High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ
中山醫學大學 2020 Satisfaction with pain management and impact of pain on quality of life in cancer patients Lin, JS; Hsieh, RK; Chen, JS; Lee, KD; Rau, KM; Shao, YY; Sung, YC; Yeh, SP; Chang, CS; Liu, TC; Wu, MF; Lee, MY; Yu, MS; Yen, CJ; Lai, PY; Hwang, WL; Chiou, TJ
國家衛生研究院 2018-10 Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study Chang, HJ;Chiu, YF;Chen, JS;Li, CP;Ho, CL;Shyr, YM;Chiou, WC;Yeh, CN;Hsieh, RK;Lin, YL;Tien, YW;Hwang, TL;Shan, YS;Chen, LT
國家衛生研究院 2017-07-31 The treatment patterns of non-metastatic prostate cancer in an Asian country Huang, EYH;Yu, HJ;Chang, YH;Wu, TT;Cha, TL;Pang, ST;Huang, SP;Pan, CC;Cheng, JCH;Hsieh, RK;Peng, RS;Ku, HY;Liu, TW
國家衛生研究院 2016-11-21 A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors Chiang, NJ;Chao, TY;Hsieh, RK;Wang, CH;Wang, YW;Yeh, CG;Chen, LT
國家衛生研究院 2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT
國家衛生研究院 2014-12 Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM
國家衛生研究院 2014-07 Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012 Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL
臺北醫學大學 2014 Association between Phosphorylated AMP-Activated Protein Kinase and Acetyl-CoA Carboxylase Expression and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck Su, YW;Lin, YH;Pai, MH;Lo, AC;Lee, YC;Fang, IC;Lin, J;Hsieh, RK;Chang, YF;Chen, CL
臺北醫學大學 2014 Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012 Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL
國家衛生研究院 2011-12 Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study Ch'ang, HJ;Lin, YL;Wang, HP;Chiu, YF;Chang, MC;Hsu, CH;Tien, YW;Chen, JS;Hsieh, RK;Lin, PW;Shan, YS;Cheng, AL;Chang, JY;Whang-Peng, J;Hwang, TL;Chen, LT
國家衛生研究院 2011-08-17 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan Chen, JS;Chao, Y;Hsieh, RK;Cheng, AL;Chen, PM;Chiou, TJ;Chao, TY;Yeh, KH;Chen, LT;Whang-Peng, J
高雄醫學大學 2011 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.  趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. 
高雄醫學大學 2011 Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.  陳立宗 ; Ch'ang HJ;Lin YL;Wang HP;Chiu YF;Chang MC;Hsu CH;Tien YW;Chen JS;Hsieh RK;Lin PW;Shan YS;Cheng AL;Chang JY;Whang-Peng J;Hwang TL;Chen LT. 
國家衛生研究院 2010-05 Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors Chen, L;Shiah, H;Chao, T;Hsieh, RK;Chen, G;Chang, J;Yeh, G
國家衛生研究院 2010-04 A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting Ho, CL;Su, WC;Hsieh, RK;Lin, ZZ;Chao, TY
國家衛生研究院 2008-06 Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors Lim, KH; Huang, MJ; Chen, LT; Wang, TE; Liu, CL; Chang, CS; Liu, MC; Hsieh, RK; Tzen, CY
國家衛生研究院 2008-05 Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan Chang, CS;Chao, Y;Chen, JS;Chen, LT;Chung, CH;Hsieh, RK;Hwang, WS;Yang, L;De Reyder, F
高雄醫學大學 2008 High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy  黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. 
國家衛生研究院 2006-07-17 An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer Chao, Y; Li, CP; Chao, TY; Su, WC; Hsieh, RK; Wu, MF; Yeh, KH; Kao, WY; Chen, LT; Cheng, AL
高雄醫學大學 2006 An open; multi-centre; phase II clinical trial to evaluate the efficacy and safety of paclitaxel; UFT; and leucovorin in patients with advanced gastric cancer.  陳立宗;鄭安理 ; Chao Y;Li CP;Chao TY;Su WC;Hsieh RK;Wu MF;Yeh KH;Kao WY;Chen LT;Cheng AL. 
國家衛生研究院 2005-06 An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report Chao, Y;Li, CP;Chao, TY;Su, WC;Hsieh, RK;Wu, MF;Yeh, KH;Chen, LT;Cheng, AL
國家衛生研究院 2004-08-02 Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer Chao, Y; Yeh, KH; Chang, CJ; Chen, LT; Chao, TY; Wu, MF; Chang, CS; Chang, JY; Chung, CY; Kao, WY; Hsieh, RK; Cheng, AL
國立臺灣大學 2004-08 Phase II study of weekly oxaliplatin and 24-hour infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Chao Y; Kun-Huei Yeh; Chang CJ; Chen LT; Chao TY; Wu MF; Chang CS; Chang JY; Chung CY; Kao WY; Hsieh RK; Cheng AL

Showing items 1-25 of 33  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page